FluoroType® HSV is based on an innovative, fluorescence-based, technology enabling the detection of Herpes simplex viruses from clinical swab specimens, liquor samples or cerebrospinal fluid.
FluoroType® HSV enables fast and reliable molecular diagnostics of HSV based on PCR with hybridization probes. HSV DNA is extracted from clinical swab specimens or liquor samples using GenoXtract® followed by amplification, detection and analysis in the FluoroCycler®. The results are available within three hours and differentiate between HSV-1 and HSV-2. In comparison to culture or serology, elaborate and time-consuming steps are eliminated. This enables the immediate initiation of an antiviral therapy as well as adequate prevention measures.
For FluoroType® HSV, bacterial DNA is extracted using the Genoxtract® nucleic acid extraction systems in combination with GXT NA Extraction Kit, in easy to use cartridges from the sample material, providing high quality nucleic acid extraction for optimal PCR performance. The subsequent amplification and detection run fully automated in the FluoroCycler® instruments. The evaluation and result interpretation is performed by the test-specific FluoroSoftware®. This guarantees maximum user-friendliness and efficient laboratory diagnostics with impeccable results at a glance.
Please contact your local representative for availability in your country.
Not for sale in the USA.
Legal Manufacturer is Hain Lifescience GmbH – A Bruker Company